Liqiang Wang
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Inflammatory Biomarkers in Disease Prognosis
- Colorectal Cancer Surgical Treatments
Papers in
-
- Circular RNAs in diseases 3
- RNA modifications and cancer 2
- Protein Degradation and Inhibitors 1
- Oncology 5
- Cytokine Signaling Pathways and Interactions 2
- Co-authors
- Min‐Bin Chen (6 shared papers)Fuquan Jiang (2 shared papers)Pei‐Hua Lu (3 shared papers)Wei Shen (2 shared papers)Yan Zhang (1 shared paper)Yiping Du (1 shared paper)Jingjing Lu (1 shared paper)Xiao‐Yang Wu (2 shared papers)
- Journals
- PLoS ONE (2 papers)Medicine (1 paper)BioMed Research International (1 paper)Translational Lung Cancer Research (1 paper)Journal of Gastroenterology and Hepatology (1 paper)
- Partner nations
- ChinaUnited StatesIsrael
In The Last Decade
Liqiang Wang
18 papers receiving 407 citations
Peers
Comparison fields: 5 of 58
- Cancer Research 117
- Oncology 170
- Immunology 73
- Molecular Biology 133
- Endocrine and Autonomic Systems 11
Countries citing papers authored by Liqiang Wang
This map shows the geographic impact of Liqiang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liqiang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liqiang Wang more than expected).
Fields of papers citing papers by Liqiang Wang
This network shows the impact of papers produced by Liqiang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liqiang Wang. The network helps show where Liqiang Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Liqiang Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 76 | |
| 2 | 2012 | 71 | |
| 3 | 2019 | 37 | |
| 4 | 2018 | 37 | |
| 5 | 2017 | 35 | |
| 6 | 2012 | 33 | |
| 7 | Circ_0006790 carried by bone marrow mesenchymal stem cell-derived exosomes regulates S100A11 DNA methylation through binding to CBX7 in pancreatic ductal adenocarcinoma. | 2022 | 21 |
| 8 | 2017 | 19 | |
| 9 | 2012 | 18 | |
| 10 | 2023 | 16 | |
| 11 | 2021 | 10 | |
| 12 | 2020 | 9 | |
| 13 | 2017 | 8 | |
| 14 | 2021 | 7 | |
| 15 | 2020 | 6 | |
| 16 | 2023 | 3 | |
| 17 | 2024 | 2 | |
| 18 | 2009 | 1 |
About Liqiang Wang
Liqiang Wang is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 409 indexed citations. Recurring topics across this work include Circular RNAs in diseases (3 papers), interferon and immune responses (3 papers), Cancer-related molecular mechanisms research (3 papers), MicroRNA in disease regulation (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), RNA modifications and cancer (2 papers), Protein Degradation and Inhibitors (1 paper) and Drug Solubulity and Delivery Systems (1 paper). The work is most often cited by research in Cancer Research (117 citations), Oncology (170 citations), Immunology (73 citations), Molecular Biology (133 citations) and Endocrine and Autonomic Systems (11 citations). Liqiang Wang has collaborated with scholars based in China, United States and Israel. Frequent co-authors include Min‐Bin Chen, Fuquan Jiang, Pei‐Hua Lu, Wei Shen, Yan Zhang, Yiping Du, Jingjing Lu, Xiao‐Yang Wu, Rong Yu and Chen Li. Their work appears in journals such as PLoS ONE, Medicine, BioMed Research International, Translational Lung Cancer Research and Journal of Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.